|
HAUS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81843429203354E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3510970947882E-11 |
| Normal-vs-Stage2 |
1.44599999973849E-07 |
| Normal-vs-Stage3 |
1.15010001522364E-09 |
| Normal-vs-Stage4 |
1.79869996674853E-09 |
| Stage1-vs-Stage2 |
4.743800E-01 |
| Stage1-vs-Stage3 |
2.344000E-01 |
| Stage1-vs-Stage4 |
1.188220E-01 |
| Stage2-vs-Stage3 |
8.724600E-01 |
| Stage2-vs-Stage4 |
5.229800E-01 |
| Stage3-vs-Stage4 |
6.047800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05426778418405E-12 |
| Normal-vs-AfricanAmerican |
8.14330000000751E-05 |
| Normal-vs-Asian |
3.65530000000502E-05 |
| Caucasian-vs-AfricanAmerican |
8.054000E-01 |
| Caucasian-vs-Asian |
2.450600E-01 |
| AfricanAmerican-vs-Asian |
5.903400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.71620004266282E-09 |
| Normal-vs-Female |
1.94233518158171E-12 |
| Male-vs-Female |
3.532000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.10120049032514E-10 |
| Normal-vs-Age(41-60Yrs) |
1.89019910834531E-11 |
| Normal-vs-Age(61-80Yrs) |
1.20510001977436E-09 |
| Normal-vs-Age(81-100Yrs) |
4.581500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.985400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.672000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.774000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.842800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.413200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.478600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.716700E-03 |
| Classical-VS-Follicular |
6.882200E-01 |
| Classical-VS-Other |
7.888200E-01 |
| Classical-VS-Normal |
1.85349513515121E-11 |
| Tall-VS-Follicular |
1.953840E-02 |
| Tall-VS-Other |
2.108400E-01 |
| Tall-VS-Normal |
5.99610361362579E-11 |
| Follicular-VS-Other |
9.332400E-01 |
| Follicular-VS-Normal |
3.79539999983969E-07 |
| Other-VS-Normal |
1.289950E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5251999663235E-10 |
| Normal-vs-N1 |
4.46740000548118E-08 |
| N0-vs-N1 |
6.851600E-01 |
|
|
